IP Library › Granted Patent US 11,382,926
Granted Patent B2
US 11,382,926 · App. 17/222,066 · Granted Jul 12, 2022

Methods for treating

Inventors: Michael O'Neil Hanrahan Clarke (Redwood City, CA); Joy Yang Feng (Hillsborough, CA); Robert Jordan (Foster City, CA); Richard L. Mackman (Millbrae, CA); Adrian S. Ray (Burlingame, CA); Dustin Siegel (Half Moon Bay, CA)
Assignee: Gilead Sciences, Inc.
A61K31/706A61K31/7056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,382,926
App. No.
17/222,066
Granted
Jul 12, 2022
Kind
B2
Abstract

Provided are methods for treating Arenaviridae and Coronaviridae virus infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1′ position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are particularly useful for the treatment of Lassa virus and Junin virus infections.

Claims (57)

1. A method for treating Coronaviridae infection in a human in need thereof, comprising administering a therapeutically effective amount of a compound of Formula III:

or a pharmaceutically acceptable salt thereof;

wherein

R 2 and R 3 are each OR a ;

R 6 is CN;

R 7 is —(C═O)R 11 or

R 8 is NH 2 ;

R 9 is H;

each occurrence of R a is independently H or —(C═O)R;

R 11 is H or (C 1 -C 8 )alkyl which is optionally substituted by NH 2 ;

each occurrence of R is independently H or (C 1 -C 8 )alkyl which is optionally substituted by NH 2 ;

R f is H or (C 1 -C 8 )alkyl; and

one or more hydrogens attached to a carbon of the compound are optionally replaced by deuterium.

2. The method of claim 1 , wherein R 7 is

3. The method of claim 2 , wherein R f is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl.

4. The method of claim 1 , wherein R 2 and R 3 are each OH.

5. The method of claim 4 , wherein R 7 is —(C═O)R 11 and R 11 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

6. The method of claim 5 , wherein R 11 is —CH(CH 3 ) 2 .

7. The method of claim 5 , wherein R 11 is —CH(NH 2 )CH(CH 3 ) 2 .

8. The method of claim 5 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

9. The method of claim 6 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

10. The method of claim 7 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

11. The method of claim 1 , wherein R 2 and R 3 are each —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl groups of R 2 and R 3 are each optionally substituted with NH 2 .

12. The method of claim 11 , wherein the (C 1 -C 8 )alkyl groups of R 2 and R 3 are each selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted with NH 2 .

13. The method of claim 12 , wherein each of R 2 and R 3 is selected from the group consisting of —O(C═O)—CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

14. The method of claim 13 , wherein R 2 and R 3 are —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 and —O(C═O)—CH(CH 3 ) 2 , respectively; —O(C═O)—CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 , respectively; or —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 , respectively.

15. The method of claim 13 , wherein R 2 and R 3 are each —O(C═O)—CH(CH 3 ) 2 .

16. The method of claim 11 , wherein R 7 is —(C═O)R 11 and R 11 is —(C 1 -C 8 )alkyl optionally substituted by NH 2 .

17. The method of claim 16 , wherein R 11 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

18. The method of claim 17 , wherein R 11 is —CH(CH 3 ) 2 .

19. The method of claim 17 , wherein R 11 is —CH(NH 2 )CH(CH 3 ) 2 .

20. The method of claim 11 , wherein R 2 is —O(C═O)—CH(CH 3 ) 2 , R 3 is —O(C═O)—CH(CH 3 ) 2 , R 7 is —(C═O)R 11 , and R 11 is —CH(CH 3 ) 2 .

21. The method of claim 18 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

22. The method of claim 19 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

23. The method of claim 20 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

24. The method of claim 20 , wherein one hydrogen attached to a carbon of the compound is replaced by deuterium.

25. The method of claim 1 , wherein R 2 is OH and R 3 is —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl of R 3 is optionally substituted by NH 2 .

26. The method of claim 25 , wherein the (C 1 -C 8 )alkyl of R 3 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

27. The method of claim 26 , wherein R 3 is —O(C═O)—CH(CH 3 ) 2 .

28. The method of claim 26 , wherein R 3 is —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

29. The method of claim 25 , wherein R 7 is —(C═O)R 11 and R 11 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

30. The method of claim 29 , wherein R 11 is —CH(CH 3 ) 2 .

31. The method of claim 29 , wherein R 11 is —CH(NH 2 )CH(CH 3 ) 2 .

32. The method of claim 30 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

33. The method of claim 31 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

34. The method of claim 1 , wherein R 3 is OH and R 2 is —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl of R 2 is optionally substituted by NH 2 .

35. The method of claim 34 , wherein the (C 1 -C 8 )alkyl of R 2 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, or 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

36. The method of claim 35 , wherein R 2 is —O(C═O)—CH(CH 3 ) 2 .

37. The method of claim 35 , wherein R 2 is —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

38. The method of claim 34 , wherein R 7 is —(C═O)R 11 and R 11 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

39. The method of claim 38 , wherein R 11 is —CH(CH 3 ) 2 .

40. The method of claim 38 , wherein R 11 is —CH(NH 2 )CH(CH 3 ) 2 .

41. The method of claim 39 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

42. The method of claim 40 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

43. The method of claim 1 , wherein the Coronaviridae infection is caused by a SARS virus.

44. The method of claim 1 , wherein the Coronaviridae infection is caused by a Coronaviridae virus selected from the group consisting of SARS, MERS, 229E, NL63, OC43, and HKU1.

45. The method of claim 1 , wherein one or more hydrogens attached to a carbon of the compound are replaced by deuterium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2021
From: CLARKE, MICHAEL O'NEIL HANRAHAN; FENG, JOY YANG; JORDAN, ROBERT; MACKMAN, RICHARD L.; RAY, ADRIAN S.; SIEGEL, DUSTIN
To: GILEAD SCIENCES, INC.
Reel/Frame 057082/0261 →
Continuity (6)
Continuation 16863566 · Apr 30, 2020
Continuation 16265016 · Feb 1, 2019
Continuation 15267433 · Sep 16, 2016
Provisional Application 62239696 · Oct 9, 2015
Provisional Application 62219302 · Sep 16, 2015
Related Publication 20210393659A1 · Dec 23, 2021
Cited By (6)
US 12,297,226 US 12,357,577 US 12,404,289 US 12,448,383 US 12,509,466 US 12,655,172